Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies

dc.creatorSingh, Awadhesh Kumar
dc.creatorSingh, Akriti
dc.creatorRituSingh, Ritu
dc.creatorMisra, Anoop
dc.date.accessioned2020-07-24T19:51:49Z
dc.date.accessioned2022-09-23T18:51:08Z
dc.date.available2020-07-24T19:51:49Z
dc.date.available2022-09-23T18:51:08Z
dc.date.created2020-07-24T19:51:49Z
dc.identifier1871-4021
dc.identifierhttps://www.sciencedirect.com/science/article/pii/S1871402120301375?via%3Dihub
dc.identifierhttp://hdl.handle.net/20.500.12010/11121
dc.identifierhttps://doi.org/10.1016/j.dsx.2020.05.018
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3508552
dc.publisherDiabetes & Metabolic Syndrome: Clinical Research & Reviews
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourcereponame:Expeditio Repositorio Institucional UJTL
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozano
dc.subjectRemdesivir
dc.subjectClinical outcome
dc.subjectMortality
dc.titleRemdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies


Este ítem pertenece a la siguiente institución